Filed: 2/14/2023ACC: 0001104659-23-020685
📋 What this filing means
NEXTECH INVEST LTD. filed this quarterly 13F‑HR report disclosing 14 equity positions with a total reported market value of $251.36M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
14
Positions
$251.36M
Total AUM (reported)
30.31M
Total Shares
Allocation by class
COM$249.15M99.1%
COM STK$2.22M0.9%
Portfolio Concentration
Top 3$151.17M60.1%
4–10$85.47M34.0%
11–25$14.72M5.9%
Top 3 weight
60.1%
Top 10 weight
94.1%
Voting Authority Distribution
Total shares with voting rights: 30.31M
Sole
Full voting authority
30.31M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole14
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings14
Rows:
REVOLUTION MEDICINES INC
SOLEShares4.19M
TypeSH
Market value$99.79M
39.70%
Sole
4.19M
Shared
0.00
None
0.00
EQRX INC
SOLEShares13.10M
TypeSH
Market value$32.24M
12.82%
Sole
13.10M
Shared
0.00
None
0.00
TYRA BIOSCIENCES INC
SOLEShares2.52M
TypeSH
Market value$19.14M
7.61%
Sole
2.52M
Shared
0.00
None
0.00
ARS PHARMACEUTICALS INC
SOLEShares1.91M
TypeSH
Market value$16.29M
6.48%
Sole
1.91M
Shared
0.00
None
0.00
KINNATE BIOPHARMA INC
SOLEShares2.33M
TypeSH
Market value$14.21M
5.65%
Sole
2.33M
Shared
0.00
None
0.00
CULLINAN ONCOLOGY INC
SOLEShares1.22M
TypeSH
Market value$12.88M
5.13%
Sole
1.22M
Shared
0.00
None
0.00
PMV PHARMACEUTICALS INC
SOLEShares1.39M
TypeSH
Market value$12.06M
4.80%
Sole
1.39M
Shared
0.00
None
0.00
MIRATI THERAPEUTICS INC
SOLEShares263.91K
TypeSH
Market value$11.96M
4.76%
Sole
263.91K
Shared
0.00
None
0.00
ARVINAS INC
SOLEShares287.25K
TypeSH
Market value$9.83M
3.91%
Sole
287.25K
Shared
0.00
None
0.00
BLUEPRINT MEDICINES CORP
SOLEShares188.23K
TypeSH
Market value$8.25M
3.28%
Sole
188.23K
Shared
0.00
None
0.00
RELAY THERAPEUTICS INC
SOLEShares475.49K
TypeSH
Market value$7.10M
2.83%
Sole
475.49K
Shared
0.00
None
0.00
THESEUS PHARMACEUTICALS INC
SOLEShares611.31K
TypeSH
Market value$3.04M
1.21%
Sole
611.31K
Shared
0.00
None
0.00
KRONOS BIO INC
SOLEShares1.45M
TypeSH
Market value$2.35M
0.94%
Sole
1.45M
Shared
0.00
None
0.00
C4 THERAPEUTICS INC
SOLEShares375.86K
TypeSH
Market value$2.22M
0.88%
Sole
375.86K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
REVOLUTION MEDICINES INCSOLE | COM | 4.19M | SH | $99.79M 39.70% | 4.19M | 0.00 | 0.00 |
EQRX INCSOLE | COM | 13.10M | SH | $32.24M 12.82% | 13.10M | 0.00 | 0.00 |
TYRA BIOSCIENCES INCSOLE | COM | 2.52M | SH | $19.14M 7.61% | 2.52M | 0.00 | 0.00 |
ARS PHARMACEUTICALS INCSOLE | COM | 1.91M | SH | $16.29M 6.48% | 1.91M | 0.00 | 0.00 |
KINNATE BIOPHARMA INCSOLE | COM | 2.33M | SH | $14.21M 5.65% | 2.33M | 0.00 | 0.00 |
CULLINAN ONCOLOGY INCSOLE | COM | 1.22M | SH | $12.88M 5.13% | 1.22M | 0.00 | 0.00 |
PMV PHARMACEUTICALS INCSOLE | COM | 1.39M | SH | $12.06M 4.80% | 1.39M | 0.00 | 0.00 |
MIRATI THERAPEUTICS INCSOLE | COM | 263.91K | SH | $11.96M 4.76% | 263.91K | 0.00 | 0.00 |
ARVINAS INCSOLE | COM | 287.25K | SH | $9.83M 3.91% | 287.25K | 0.00 | 0.00 |
BLUEPRINT MEDICINES CORPSOLE | COM | 188.23K | SH | $8.25M 3.28% | 188.23K | 0.00 | 0.00 |
RELAY THERAPEUTICS INCSOLE | COM | 475.49K | SH | $7.10M 2.83% | 475.49K | 0.00 | 0.00 |
THESEUS PHARMACEUTICALS INCSOLE | COM | 611.31K | SH | $3.04M 1.21% | 611.31K | 0.00 | 0.00 |
KRONOS BIO INCSOLE | COM | 1.45M | SH | $2.35M 0.94% | 1.45M | 0.00 | 0.00 |
C4 THERAPEUTICS INCSOLE | COM STK | 375.86K | SH | $2.22M 0.88% | 375.86K | 0.00 | 0.00 |